Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramelteon for insomnia in patients with major depressive disorder (actigraphy study)
jRCT1080223089Phase 4Completed
- Sponsor
- Takeda
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ramelteon in major depressive disorder (MDD) and Insomnia, sponsored by Takeda. Started Jan 2016; status: completed.
02
Drugs
ramelteon
03
Conditions
major depressive disorder (MDD)Insomnia
Beyond the preview
Go deeper on jRCT1080223089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223089.